Business Description
Matinas BioPharma Holdings Inc
NAICS : 325412
SIC : 2834
ISIN : US5768101058
Description
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.42 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | -0.14 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 84.7 | |||||
| 3-Year EBITDA Growth Rate | 4.1 | |||||
| 3-Year EPS without NRI Growth Rate | 3.6 | |||||
| 3-Year FCF Growth Rate | 6.9 | |||||
| 3-Year Book Growth Rate | -33.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.06 | |||||
| 9-Day RSI | 34.06 | |||||
| 14-Day RSI | 35.64 | |||||
| 6-1 Month Momentum % | -55.92 | |||||
| 12-1 Month Momentum % | -23.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.39 | |||||
| Quick Ratio | 6.39 | |||||
| Cash Ratio | 5.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.8 | |||||
| Shareholder Yield % | -48.89 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -1644.98 | |||||
| ROE % | -110.25 | |||||
| ROA % | -86.2 | |||||
| ROIC % | -231.69 | |||||
| 3-Year ROIIC % | -172.27 | |||||
| ROC (Joel Greenblatt) % | -458.89 | |||||
| ROCE % | -98.95 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 14.03 | |||||
| PB Ratio | 0.93 | |||||
| Price-to-Tangible-Book | 1.2 | |||||
| EV-to-EBIT | -0.28 | |||||
| EV-to-EBITDA | -0.29 | |||||
| EV-to-Revenue | 6.08 | |||||
| EV-to-Forward-Revenue | 61.76 | |||||
| EV-to-FCF | -0.37 | |||||
| Price-to-Net-Current-Asset-Value | 1.77 | |||||
| Price-to-Net-Cash | 1.96 | |||||
| Earnings Yield (Greenblatt) % | -357.14 | |||||
| FCF Yield % | -100.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Matinas BioPharma Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.005 | ||
| EPS (TTM) (€) | -5.09 | ||
| Beta | 0.47 | ||
| Volatility % | 114.02 | ||
| 14-Day RSI | 35.64 | ||
| 14-Day ATR (€) | 0.368909 | ||
| 20-Day SMA (€) | 3.4985 | ||
| 12-1 Month Momentum % | -23.86 | ||
| 52-Week Range (€) | 1.45 - 32.5 | ||
| Shares Outstanding (Mil) | 5.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Matinas BioPharma Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Matinas BioPharma Holdings Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Matinas BioPharma Holdings Inc Frequently Asked Questions
What is Matinas BioPharma Holdings Inc(FRA:6LJ0)'s stock price today?
The current price of FRA:6LJ0 is €2.69. The 52 week high of FRA:6LJ0 is €32.50 and 52 week low is €1.45.
When is next earnings date of Matinas BioPharma Holdings Inc(FRA:6LJ0)?
The next earnings date of Matinas BioPharma Holdings Inc(FRA:6LJ0) is 2024-11-08 Est..
Does Matinas BioPharma Holdings Inc(FRA:6LJ0) pay dividends? If so, how much?
Matinas BioPharma Holdings Inc(FRA:6LJ0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers